Inspire Medical Systems, Inc. $INSP Shares Purchased by Edgestream Partners L.P.

Edgestream Partners L.P. boosted its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 358.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 82,268 shares of the company’s stock after buying an additional 64,315 shares during the period. Edgestream Partners L.P.’s holdings in Inspire Medical Systems were worth $4,243,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of INSP. CWM LLC lifted its position in Inspire Medical Systems by 216.1% in the fourth quarter. CWM LLC now owns 354 shares of the company’s stock valued at $33,000 after buying an additional 242 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in Inspire Medical Systems by 1,115.4% during the first quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company’s stock worth $33,000 after buying an additional 580 shares during the period. Havemeyer Place LP acquired a new stake in shares of Inspire Medical Systems during the fourth quarter valued at about $39,000. V Square Quantitative Management LLC acquired a new stake in shares of Inspire Medical Systems during the fourth quarter valued at about $40,000. Finally, Smartleaf Asset Management LLC raised its stake in shares of Inspire Medical Systems by 84.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock valued at $42,000 after acquiring an additional 205 shares during the period. 94.91% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

INSP has been the topic of several recent analyst reports. Royal Bank Of Canada lowered shares of Inspire Medical Systems from a “sector perform” rating to a “buy” rating in a report on Monday, June 15th. Wells Fargo & Company lowered their price objective on shares of Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 5th. Zacks Research upgraded shares of Inspire Medical Systems from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Robert W. Baird cut their target price on Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Finally, Piper Sandler cut Inspire Medical Systems from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $85.00 to $55.00 in a research note on Tuesday, May 5th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, thirteen have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, Inspire Medical Systems presently has a consensus rating of “Hold” and an average price target of $73.28.

Inspire Medical Systems Price Performance

NYSE INSP opened at $50.28 on Friday. The company has a market cap of $1.45 billion, a P/E ratio of 11.20, a P/E/G ratio of 5.06 and a beta of 0.71. The stock has a 50-day moving average of $45.98 and a two-hundred day moving average of $55.75. Inspire Medical Systems, Inc. has a 1-year low of $38.91 and a 1-year high of $147.03.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.38. The company had revenue of $204.58 million for the quarter, compared to analyst estimates of $200.04 million. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The business’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.10 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. On average, analysts anticipate that Inspire Medical Systems, Inc. will post 0.93 EPS for the current fiscal year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.